Share on Facebook
Share on Twitter
Share via e-mail
Share on Google Bookmarks
Share on LiveJournal
Share on Newsvine
Share on Reddit
Share on Stumble Upon
Share on Digg

Disclaimer: The material presented in this site is intended for public educational purposes only. The author is not offering medical or legal advice. Accuracy of information is attempted but not guaranteed. Before undertaking any diet, or health improvement program, you should consult your physician. The author is in no way liable or responsible for any bodily harm, physical, mental or emotional state of any patient reacting to any of the content on this site. has not examined, reviewed or tested any product or service mentioned herein. We are not being paid to advertise or promote any product or service mentioned herein. The links are offered strictly as examples of resources available. The site assumes no responsibility or liability of any kind related to the content of external sites or the usage of any product or service referenced. Links to external sites were live at the time of creation of the link. does not create content for or manage external sites. The information can be changed or removed by the external site’s administrators at any time and they are responsible for the veracity of their information. Links are provided to support our data and supply additional resources. Please report broken links to is not a charitable foundation. It neither accepts nor distributes donations or funds of any kind.

Medical research is pretty clear that there is little chance that GABA taken orally will penetrate the blood-brain barrier. Supplements and preparations containing “GABA” itself are misleading.

There are over-the-counter supplements that are derivatives of GABA such as Phenibut and Picamilon.

GABA injections are being tested as a cure for Type 1 diabetes, but have not been tried for SPS.

1. Awad R, Crump K, Mullally M, Sardana RK, Arnason JT, Trudeau VL. An Improved Method for Production of Recombinant Human Glutamic Acid Decarboxylase 65 for Use in Phytopharmaceutical Assessment

Pharmaceutical Biology 2008;46:1-2, 72-81

Link to article

2. Johnstone AP. Nussey SS. Direct evidence for limited clonality of antibodies to glutamic acid decarboxylase (GAD) in stiff man syndrome using baculovirus expressed GAD. J Neurol Neurosurg Psychiatry. May 1994; 57(5): 659 Link to article

1. Picamilon

Picamilon (also known as nicotinoyl-GABA, pycamilon, and pikamilon) is a dietary supplement formed by combining niacin with GABA. Picamilon is sold in the United States as a dietary supplement, while in Russia it is sold as a prescription drug.  Picamilon is able to cross the blood–brain barrier and is then hydrolyzed into GABA and niacin. The released GABA in theory would activate GABA receptors potentially producing an anxiolytic response. The second released component, niacin acts as a strong vasodilator, which might be useful for the treatment of migraine headaches. However, excessive niacin can cause cardiovascular symptoms such as flushing and fast pulse. Wikipedia.

2. Phenibut, Fenibut, Noofen, Fenigam, Phenigam, Phenybut, Phenygam, Phenylgamma, PHG, PhGABA

β-Phenyl-γ-aminobutyric acid is a derivative of the naturally occurring inhibitory neurotransmitter γ-aminobutyric acid (GABA). The addition of a phenyl ring allows phenibut to cross the blood brain barrier.

Phenibut is sold as a nutritional supplement, and is not approved as a pharmaceutical in the United States or Europe, but in Russia it is sold as a psychotropic drug. It has been reported by some to possess nootropic actions for its ability to improve neurological functions, but other researchers have not observed these effects. It is generally accepted that phenibut has anxiolytic effects.

Phenibut was discovered in the Soviet Union in the 1960s, and has since been used there to treat a wide range of ailments including post-traumatic stress disorder, anxiety, and insomnia. The effects are similar to baclofen, but less potent per milligram of dosage. Phenibut exerts its effects by being an agonist at the metabotropic GABA receptor, and at higher doses also at the ionotropic GABA receptor. It has been shown to enhance levels of dopamine.

The literature reports that phenibut has almost no negative side effects, with only an increase in sleepiness observed, however this effect is not nearly as pronounced as with benzodiazepine usage. Tolerance has been reported with extended use of high doses (e.g. 5–10 grams). There are numerous reports of withdrawal symptoms mainly due to misuse or excess. There is one reported case of withdrawal involving nervousness and shakiness, psychomotor agitation, feeling easily annoyed and irritated, fatigue, poor appetite, heart pounding and racing, nausea, insomnia, and feeling tense and keyed up.


Treatment options  GABAergic drugs   GABA A Agonists   GABA Modulators   GABA B Agonists   GABA P Agonists

GABA Transaminase   GABA RUI   GABA Analogues   GABA Supplement   Muscle Relaxers   Corticosteroids

Antiseizure   Opiate Analgesics   Experimental   IVIG   Plasmapheresis   Immunotherapy   Stem Cell Therapy  PT